People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

No significant difference seen between patients with colorectal cancer and color vision deficiency versus those without color vision deficiency.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...

As soon as the urologist said, oh it’s cancer…that is an eye-opener,” says Mark Stiegler, reflecting on his diagnosis six ...

People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...

On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...